Strategic manufacturing Leverage Cherokee’s established API development and production capabilities, FDA track record, and Merck relationships to position end-to-end contract manufacturing partnerships for highly regulated pharmaceuticals seeking reliable scale-up from concept to commercial quantities.

Expansion opportunities Target emerging and legacy pharma firms looking to expand CDMO services beyond basic manufacturing into development and fermentation capabilities, highlighting Cherokee’s large development and production footprint and rapid multi-step process handling.

Strength and stability Emphasize the parent company PRWT Services and Cherokee’s minority ownership status, long-time regulatory compliance, and a proven safety/environmental track record to reassure potential clients about risk management, continuity, and quality.

Technical excellence Promote the specialized process development team’s ability to scale complex chemistries quickly, offering custom solutions for challenging syntheses and rapid transition from lab concepts to commercial quantities to attract biotech and pharma partners.

Global tech readiness Highlight Cherokee’s tech stack and digital readiness with cloud and web technologies as a backbone for compliant batch tracking, data integrity, and customer collaboration portals, appealing to data-driven customers seeking modern CDMO partnerships.